Newron Pharmaceuticals S.p.A. (NWRN.SW) - Stock Prices, Stock Peers & Analysis

Home
NWRN.SW

Company Name	Newron Pharmaceuticals S.p.A.
Symbol	NWRN.SW
Currency	CHF
Price	8
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	152,471,200
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	4.09 - 11.2
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Stefan Weber
Website	https://www.newron.com

An error occurred while fetching data.

About Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for